Chief Financial Officer
Brian C. Stephenson, Ph.D., CFA, is the Chief Financial Officer of Faeth Therapeutics, Inc. (Nasdaq: FTH), a clinical-stage biotechnology company focused on rethinking cancer treatment through a mechanistic understanding of metabolism.[[1]](https://insights.parksquare.com/post/102n674/park-square-places-brian-stephenson-ph-d-c-f-a-as-chief-financial-officer-at)[[2]](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-fth/faeth-therapeutics/management) As CFO, he oversees corporate finance, capital strategy, and investor relations, and has recently reported significant open‑market purchases of Faeth common stock through the Brian Stephenson Revocable Trust, reflecting indirect ownership of company shares and stock options disclosed in SEC filings.[[3]](https://uk.investing.com/news/stock-market-news/faeth-therapeutics-cfo-brian-c-stephenson-buys-405920-in-stock-93CH-4743414?ampMode=1)[[5]](https://www.stocktitan.net/sec-filings/FTH/form-4-sensei-biotherapeutics-inc-insider-trading-activity-c6f8a8fce7ea.html)[[6]](https://longbridge.com/en/news/290611234)[[8]](https://www.stocktitan.net/sec-filings/SNSE/)[[9]](https://www.dataroma.com/m/ins/ins.php?t=y2&fr=2014-11-05&to=2014-12-04&rid=1780030&po=&so=&tp=&am=0&sym=&o=td&d=d)
Stephenson is a seasoned healthcare and life sciences finance executive whose prior roles include serving as Chief Financial Officer and Secretary of BridgeBio Pharma, Inc., where he helped build the company from its founding in 2015 through its IPO and growth into a commercial-stage biopharmaceutical organization.[[1]](https://insights.parksquare.com/post/102n674/park-square-places-brian-stephenson-ph-d-c-f-a-as-chief-financial-officer-at)[[7]](https://www.linkedin.com/in/brianstephenson-phd-cfa) Before BridgeBio, he was Partner and Head of Life Sciences at Capital IP Investment Partners, held Director and Vice President positions at Leerink Partners, and began his career in management consulting at McKinsey & Company.[[1]](https://insights.parksquare.com/post/102n674/park-square-places-brian-stephenson-ph-d-c-f-a-as-chief-financial-officer-at)[[7]](https://www.linkedin.com/in/brianstephenson-phd-cfa) He holds a Ph.D. and M.S. in Chemical Engineering from the Massachusetts Institute of Technology and a B.S. in Chemical Engineering from Brigham Young University, and is a CFA charterholder, combining deep scientific training with advanced financial expertise in biotechnology and healthcare investing.[[1]](https://insights.parksquare.com/post/102n674/park-square-places-brian-stephenson-ph-d-c-f-a-as-chief-financial-officer-at)[[7]](https://www.linkedin.com/in/brianstephenson-phd-cfa)
查看完整内部人档案 →